Document Detail

Pharmacology of apolipoprotein A-I.
MedLine Citation:
PMID:  9253539     Owner:  NLM     Status:  MEDLINE    
The role of HDL and its main protein component the apolipoprotein A-I as being antiatherogenic is well established. Experimental data give support for the involvement of at least three different types of mechanism: (1) the reverse cholesterol transport, (2) anti-inflammatory mechanisms and (3) antithrombotic mechanisms. Depending upon the stage and type of atherosclerosis, different mechanisms may be more or less important. Knowledge of pharmacology of apolipoprotein A-I has strongly increased during past years and clinical studies have started with infusions of apolipoprotein A-I phospholipid complexes.
L O Andersson
Related Documents :
7240969 - Plasma lipoprotein changes resulting from immunologically blocked lipolysis.
3217749 - Enzymatic determination of high density lipoprotein phospholipid using a sensitive reag...
9253539 - Pharmacology of apolipoprotein a-i.
6438429 - The distribution of serum high density lipoprotein subfractions in non-human primates.
15909059 - Increased serum high-density lipoprotein cholesterol level is associated with a reducti...
9719399 - Moderate doses of alcoholic beverages with dinner and postprandial high density lipopro...
19445819 - The effects of a low-sodium base-producing diet including red meat compared with a high...
15277429 - Non-hdl cholesterol and apolipoprotein b predict cardiovascular disease events among me...
23406619 - Addition of capsaicin and exchange of carbohydrate with protein counteract energy intak...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in lipidology     Volume:  8     ISSN:  0957-9672     ISO Abbreviation:  Curr. Opin. Lipidol.     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1997-10-23     Completed Date:  1997-10-23     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  9010000     Medline TA:  Curr Opin Lipidol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  225-8     Citation Subset:  IM    
Cardiocon AB, Knivsta, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents, Non-Steroidal / pharmacology
Anticholesteremic Agents / pharmacology
Anticoagulants / pharmacology
Apolipoprotein A-I / pharmacology*
Arteriosclerosis / metabolism*
Biological Transport
Cholesterol / metabolism
Lipoproteins, HDL / metabolism*
Phospholipids / pharmacology*
Reg. No./Substance:
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Anticholesteremic Agents; 0/Anticoagulants; 0/Apolipoprotein A-I; 0/Lipoproteins, HDL; 0/Phospholipids; 0/apolipoprotein A-I Milano; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High density lipoprotein and coronary heart disease: insights from mutations leading to low high den...
Next Document:  The menopause and lipid metabolism: strategies for cardiovascular disease prevention.